Achieve reports financial results for third quarter 2021 and provides update on cytisinicline development

Seattle, wash and vancouver, british columbia, nov. 09, 2021 (globe newswire) -- -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced third quarter 2021 financial results and provided an update on the cytisinicline clinical development program.
ACHV Ratings Summary
ACHV Quant Ranking